Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Juvenescence is a clinical-stage drug development company focused on extending healthy lifespan through innovative medicines that target core aging mechanisms. Their business model emphasizes early…

Juvenescence is a clinical-stage drug development company focused on extending healthy lifespan through innovative medicines that target core aging mechanisms. Their business model emphasizes early…
Stage: Clinical-stage
Focus: Drugs targeting core mechanisms of aging to extend healthy lifespan
Founded: 2016
Recent financing: $76M first close of Series B-1 (May 2025) led by M42
Headcount (reported): 40
Age-related diseases and mechanisms of ageing
2016
Biotechnology
$76M
First close of Series B-1; described as a strategic partnership with M42
Reported as a Series B on Apr 16, 2025
“Strategic investment and partnership with M42 (Abu Dhabi) announced in April 2025; follow-on investments from existing backers reported”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
60,000+
Open Roles
300+
New This Week